应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
06667 美因基因
休市中 11-20 15:33:40
6.895
-0.135
-1.92%
最高
6.895
最低
6.890
成交量
3,000
今开
6.895
昨收
7.030
日振幅
0.07%
总市值
15.17亿
流通市值
15.17亿
总股本
2.20亿
成交额
2.07万
换手率
0.00%
流通股本
2.20亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
美因基因回购5.5万股股份,耗资约37.72万港元
公告速递 · 11-19 21:26
美因基因回购5.5万股股份,耗资约37.72万港元
美因基因(06667)11月19日斥资37.7万港元回购5.5万股
智通财经 · 11-19 21:25
美因基因(06667)11月19日斥资37.7万港元回购5.5万股
美因基因(06667.HK)11月19日斥资37.7万港元回购5.5万股
智通财经 · 11-19 21:25
美因基因(06667.HK)11月19日斥资37.7万港元回购5.5万股
俞熔减持美因基因(06667)100万股 每股作价5.5港元
智通财经 · 11-18
俞熔减持美因基因(06667)100万股 每股作价5.5港元
美因基因:俞熔减持,好仓比例降至17.74%
港股披露 · 11-17
美因基因:俞熔减持,好仓比例降至17.74%
美因基因(06667)11月27日召开发特别股东大会 拟将基因检测服务年度上限调升至3.8亿元
公告速递 · 11-11
美因基因(06667)11月27日召开发特别股东大会 拟将基因检测服务年度上限调升至3.8亿元
美因基因2026年中期财报:消费级基因检测服务收入7,683.20万元,同比增长1.26%
公告速递 · 11-11
美因基因2026年中期财报:消费级基因检测服务收入7,683.20万元,同比增长1.26%
美因基因(06667)通函寄发时间顺延至11月13日前
公告速递 · 11-09
美因基因(06667)通函寄发时间顺延至11月13日前
美因基因(06667.HK)11月9日斥资76.13万港元回购11.06万股
智通财经 · 11-09
美因基因(06667.HK)11月9日斥资76.13万港元回购11.06万股
美因基因(06667)11月9日斥资76.13万港元回购11.06万股
智通财经 · 11-09
美因基因(06667)11月9日斥资76.13万港元回购11.06万股
美因基因回购11.06万股股份,耗资约76.13万港元
公告速递 · 11-09
美因基因回购11.06万股股份,耗资约76.13万港元
美因基因(06667)拟续签框架协议 2027—2029年对美年大健康及俞博士关连交易上限分别至6.28亿元、5030万元
公告速递 · 11-06
美因基因(06667)拟续签框架协议 2027—2029年对美年大健康及俞博士关连交易上限分别至6.28亿元、5030万元
美年健康(002044.SZ)拟与美因基因签署框架合作协议
智通财经 · 11-06
美年健康(002044.SZ)拟与美因基因签署框架合作协议
美因基因回购1600股股份,总额约1.09万港元
公告速递 · 11-05
美因基因回购1600股股份,总额约1.09万港元
美因基因(06667.HK)11月5日斥资1.09万港元回购1600股
智通财经 · 11-05
美因基因(06667.HK)11月5日斥资1.09万港元回购1600股
美因基因回购9.84万股股份,总额约68.04万港元
公告速递 · 11-04
美因基因回购9.84万股股份,总额约68.04万港元
美因基因(06667)11月4日斥资68.04万港元回购9.84万股
智通财经 · 11-04
美因基因(06667)11月4日斥资68.04万港元回购9.84万股
美因基因回购5,200股股份,耗资约3.67万港元
公告速递 · 11-03
美因基因回购5,200股股份,耗资约3.67万港元
美因基因更新2026年10月股份变动月报表,股本保持稳定
公告速递 · 11-02
美因基因更新2026年10月股份变动月报表,股本保持稳定
美因基因(06667)11月2日斥资39.76万港元回购5.66万股
智通财经 · 11-02
美因基因(06667)11月2日斥资39.76万港元回购5.66万股
暂无数据
公司概况
公司名称:
美因基因
所属市场:
SEHK
上市日期:
--
主营业务:
美因基因有限公司是一家主要提供基因检测服务及癌症筛查服务的投资控股公司。该公司主要通过消费级基因检测分部和癌症筛查服务分部开展业务。该公司的检测服务包括脑健康评估检测套餐、营养吸收能力评估检测套餐、帕金森病风险评估、全面癌症风险评估套餐、心脑血管疾病风险评估套餐等。该公司也提供体外诊断(IVD)管线产品,包括消费级基因检测产品和疾病筛查产品。该公司主要在国内市场开展业务。
发行价格:
--
{"stockData":{"symbol":"06667","market":"HK","secType":"STK","nameCN":"美因基因","latestPrice":6.895,"timestamp":1795160020357,"preClose":7.03,"halted":0,"volume":3000,"delay":0,"changeRate":-0.01920341394025614,"floatShares":220000000,"shares":220000000,"eps":0.136851,"marketStatus":"休市中","change":-0.135,"latestTime":"11-20 15:33:40","open":6.895,"high":6.895,"low":6.89,"amount":20679,"amplitude":0.000711,"askPrice":6.9,"askSize":100000,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":0.128,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1795397400000},"marketStatusCode":7,"adr":0,"listingDate":1655827200000,"exchange":"SEHK","adjPreClose":7.03,"dividendRate":0.025597,"openAndCloseTimeList":[[1795138200000,1795147200000],[1795150800000,1795161600000]],"volumeRatio":0.12155591537646214,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/06667/tweets","defaultTab":"tweets","newsList":[{"id":"1121281573","title":"美因基因回购5.5万股股份,耗资约37.72万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1121281573","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1121281573?lang=zh_cn&edition=full","pubTime":"2026-11-19 21:26","pubTimestamp":1795094761,"startTime":"0","endTime":"0","summary":"美因基因有限公司于2026年11月19日发布公告,称当日通过香港联交所场内交易回购股份5.5万股,约占该公司既有已发行股本的0.025%。最高回购价每股6.885港元,最低回购价每股6.67港元,合计涉资约37.72万港元。根据该公司于2026年5月21日获通过的股份回购授权,回购上限为22,430,020股,截至目前已累计回购4,172,800股,占授权批复时已发行股份数目的约1.8604%。公司确认,此次回购已获董事会正式授权并遵守相关上市规则及法律法规的要求。该公告由公司董事姜晶签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"美因基因回购5.5万股股份,耗资约37.72万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06667"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2684974354","title":"美因基因(06667)11月19日斥资37.7万港元回购5.5万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2684974354","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2684974354?lang=zh_cn&edition=full","pubTime":"2026-11-19 21:25","pubTimestamp":1795094712,"startTime":"0","endTime":"0","summary":"智通财经APP讯,美因基因(06667)发布公告,于2026年11月19日斥资37.7万港元回购5.5万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1525939.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06667","BK1219"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2684974352","title":"美因基因(06667.HK)11月19日斥资37.7万港元回购5.5万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2684974352","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2684974352?lang=zh_cn&edition=full","pubTime":"2026-11-19 21:25","pubTimestamp":1795094712,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1219","06667"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2684275963","title":"俞熔减持美因基因(06667)100万股 每股作价5.5港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2684275963","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2684275963?lang=zh_cn&edition=full","pubTime":"2026-11-18 15:58","pubTimestamp":1794988694,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,香港联交所最新数据显示,11月13日,俞熔减持美因基因(06667)100万股,每股作价5.5港元,总金额为550万港元。减持后最新持股数目约为3979.51万股,持股比例为17.74%。补充资料:Pursuant to the voting rights entrustment deed, Infinite Galaxy Health Limited entrusts Dr. Yu to exercise all voting rights associated with the 22,000,000 shares it held.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1524943.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["EWH","06667","BK1219"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107026963","title":"美因基因:俞熔减持,好仓比例降至17.74%","url":"https://stock-news.laohu8.com/highlight/detail?id=1107026963","media":"港股披露","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1107026963?lang=zh_cn&edition=full","pubTime":"2026-11-17 17:41","pubTimestamp":1794908462,"startTime":"0","endTime":"0","summary":"俞熔于2026年11月13日以每股均价5.50港元场外卖出美因基因(06667)股份100.00万股,涉资约550.00万港元;该笔为场外交易(代价性质:现金),未经联交所公开市场撮合,不属二级市场直接买卖。俞熔此次减持前持有美因基因好仓4079.51万,占比17.88%;减持后持股量为3979.51万,好仓比例降至17.74%。原文链接:Hong Kong Exchanges and Clearing Limited","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06667"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1194898020","title":"美因基因(06667)11月27日召开发特别股东大会 拟将基因检测服务年度上限调升至3.8亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=1194898020","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1194898020?lang=zh_cn&edition=full","pubTime":"2026-11-11 23:00","pubTimestamp":1794409234,"startTime":"0","endTime":"0","summary":"公司提醒,持股两股或以上的股东可委任一名或多名代理出席并投票。投票结果将于会后公布。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06667"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1175181094","title":"美因基因2026年中期财报:消费级基因检测服务收入7,683.20万元,同比增长1.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=1175181094","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1175181094?lang=zh_cn&edition=full","pubTime":"2026-11-11 21:21","pubTimestamp":1794403303,"startTime":"0","endTime":"0","summary":"根据公告,2026年上半年,美因基因的消费级基因检测服务取得人民币76,832千元收入,较去年同期的75,872千元增长1.26%。同时,公司配套服务及相关产品在报告期内实现收入约人民币1.1亿元,主要来自向体检中心、医院及其他医疗保健机构销售检测试剂券、叶酸检测试剂等配套耗材,这部分产品的销售毛利率为28.6%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"美因基因2026年中期财报:消费级基因检测服务收入7,683.20万元,同比增长1.26%","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06667"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1147197056","title":"美因基因(06667)通函寄发时间顺延至11月13日前","url":"https://stock-news.laohu8.com/highlight/detail?id=1147197056","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1147197056?lang=zh_cn&edition=full","pubTime":"2026-11-09 22:06","pubTimestamp":1794233165,"startTime":"0","endTime":"0","summary":"11月9日,美因基因有限公司(06667)公告称,原计划于2026年11月9日或之前寄发的有关建议修订2024年美年框架协议项下2026年度上限的通函,将顺延至2026年11月13日或之前寄发。 \n \n公司解释,此次延期主要因需额外时间编制及落实通函所载若干资料。通函内容将包括:(i)建议修订2026年度上限的进一步详情;(ii)独立董事委员会的推荐建议;(iii)独立财务顾问的意见;以及(iv)股东特别大会通告。 \n \n美因基因表示,除寄发时间调整外,通函其他相关安排维持不变。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06667"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682938385","title":"美因基因(06667.HK)11月9日斥资76.13万港元回购11.06万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2682938385","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682938385?lang=zh_cn&edition=full","pubTime":"2026-11-09 20:46","pubTimestamp":1794228406,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1219","06667"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682856383","title":"美因基因(06667)11月9日斥资76.13万港元回购11.06万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2682856383","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682856383?lang=zh_cn&edition=full","pubTime":"2026-11-09 20:46","pubTimestamp":1794228406,"startTime":"0","endTime":"0","summary":"智通财经APP讯,美因基因(06667)发布公告,于2026年11月9日斥资76.13万港元回购11.06万股。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1520674.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06667","BK1219"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1100682876","title":"美因基因回购11.06万股股份,耗资约76.13万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1100682876","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1100682876?lang=zh_cn&edition=full","pubTime":"2026-11-09 20:46","pubTimestamp":1794228391,"startTime":"0","endTime":"0","summary":"美因基因有限公司于2026年11月9日发布公告,披露其在香港联交所场内回购股份。公司本次合计回购股份110,600股,占回购前已发行股本约0.0502%,每股回购价介乎港币6.87港元至6.89港元,涉及总金额约76.13万港元。回购完成后,公司已发行股本保持在224,300,200股不变,其中220,182,400股为流通股,4,117,800股为库藏股。根据公告,本次股份回购基于2026年5月21日通过的购回授权进行,该授权总数为22,430,020股,公司迄今已于香港联交所及其他交易所合计回购4,117,800股,占授权总数的1.8358%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"美因基因回购11.06万股股份,耗资约76.13万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06667"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1125970484","title":"美因基因(06667)拟续签框架协议 2027—2029年对美年大健康及俞博士关连交易上限分别至6.28亿元、5030万元","url":"https://stock-news.laohu8.com/highlight/detail?id=1125970484","media":"公告速递","labels":["corporation","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1125970484?lang=zh_cn&edition=full","pubTime":"2026-11-06 22:25","pubTimestamp":1793975156,"startTime":"0","endTime":"0","summary":"建议年度上限:2027年度4.75亿元、2028年度5.46亿元、2029年度6.28亿元。载有交易详情、独立董事委员会建议、独立财务顾问意见及股东特别大会通告的通函,预计将于2026年12月1日或之前寄发。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06667"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681850308","title":"美年健康(002044.SZ)拟与美因基因签署框架合作协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2681850308","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2681850308?lang=zh_cn&edition=full","pubTime":"2026-11-06 18:57","pubTimestamp":1793962672,"startTime":"0","endTime":"0","summary":"本次公司拟与美因基因签署《框架合作协议》系日常经营所需,有利于发挥双方业务协同效应、稳定检测服务及耗材供应,契合公司发展战略,有助于提升公司核心竞争力,增强盈利能力与可持续发展能力。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1519853.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0196","002044","LU2097828714.EUR","LU2097828805.USD","06667","LU2097828631.EUR","LU2097828557.USD","BK0236","BK0146","BK0028","BK0114","BK1219","BK0077","LU2097828474.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136623852","title":"美因基因回购1600股股份,总额约1.09万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1136623852","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1136623852?lang=zh_cn&edition=full","pubTime":"2026-11-05 21:20","pubTimestamp":1793884841,"startTime":"0","endTime":"0","summary":"美因基因于2026年11月5日发布公告,称当日通过香港联交所场内回购1600股普通股,约占回购前已发行股本的0.0007%。本次回购每股价格介乎6.785港元至6.805港元,总金额10,884港元。公司于2026年5月21日获得回购授权,可回购股份总数为22,430,020股,迄今累计已回购4,007,200股,占授权获得当日已发行股本的约1.7865%。公告显示,在此次回购后开展任何新股发行或库藏股出售与转让的暂止期截至2026年12月5日。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"美因基因回购1600股股份,总额约1.09万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06667"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681075816","title":"美因基因(06667.HK)11月5日斥资1.09万港元回购1600股","url":"https://stock-news.laohu8.com/highlight/detail?id=2681075816","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2681075816?lang=zh_cn&edition=full","pubTime":"2026-11-05 21:15","pubTimestamp":1793884503,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["06667","BK1219"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115556450","title":"美因基因回购9.84万股股份,总额约68.04万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1115556450","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1115556450?lang=zh_cn&edition=full","pubTime":"2026-11-04 20:06","pubTimestamp":1793793974,"startTime":"0","endTime":"0","summary":"美因基因有限公司于2026年11月4日发布公告,称公司当日回购了共计98,400股普通股,占回购前已发行股份总数约0.0446%。此次回购价格区间介乎每股6.745港元至6.995港元,合计支付约68.04万港元。根据公告,本次回购完成后,公司已发行股份总数仍为224,300,200股,发行在外股份减少至220,294,600股,库藏股数量增至4,005,600股。公司于2026年5月21日通过回购授权,可回购的股份总数为22,430,020股,截至本次回购,已有累计4,005,600股被购回,占该授权通过当日已发行股份总数约1.7858%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"美因基因回购9.84万股股份,总额约68.04万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06667"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680619055","title":"美因基因(06667)11月4日斥资68.04万港元回购9.84万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2680619055","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680619055?lang=zh_cn&edition=full","pubTime":"2026-11-04 20:04","pubTimestamp":1793793884,"startTime":"0","endTime":"0","summary":"智通财经APP讯,美因基因(06667)发布公告,于2026年11月4日斥资68.04万港元回购9.84万股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1518629.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1219","06667"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169264805","title":"美因基因回购5,200股股份,耗资约3.67万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1169264805","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1169264805?lang=zh_cn&edition=full","pubTime":"2026-11-03 20:25","pubTimestamp":1793708757,"startTime":"0","endTime":"0","summary":"美因基因于2026年11月3日公告,公司在香港联交所场内回购5,200股普通股,占该公司当日回购前已发行股本的约0.0024%。本次回购价格介乎每股7.045港元至7.05港元,合计耗资约3.67万港元。回购后,公司已发行股本增减后为220,393,000股,库藏股数为3,907,200股。根据公告,股东大会于2026年5月21日通过了购回授权,授权总额为22,430,020股。公司确认,本次回购事项遵照上市规则及相关法律法规进行,同时将自本次回购完成之日起30天内停止发行新股或出售库藏股。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"美因基因回购5,200股股份,耗资约3.67万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06667"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1105392665","title":"美因基因更新2026年10月股份变动月报表,股本保持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1105392665","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1105392665?lang=zh_cn&edition=full","pubTime":"2026-11-02 23:00","pubTimestamp":1793631652,"startTime":"0","endTime":"0","summary":"美因基因于2026年11月2日披露了截至2026年10月31日的股份变动月报表。公告显示,公司法定股本保持不变,仍为5亿股普通股,每股面值为0.0001美元,总注册股本为5万美元。根据公告,公司已发行股本总数延续为224,300,200股,与上月末持平;其中已发行股份由上月末的222,123,200股减至220,454,800股,库存股份从2,177,000股增至3,845,400股。报告期内,未出现新增发行或注销股份,但公司通过多次回购合计1,668,400股普通股,并将其转为库存股份,回购价格区间约为每股6.99至7.26港元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06667"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680750435","title":"美因基因(06667)11月2日斥资39.76万港元回购5.66万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2680750435","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680750435?lang=zh_cn&edition=full","pubTime":"2026-11-02 21:27","pubTimestamp":1793626073,"startTime":"0","endTime":"0","summary":"智通财经APP讯,美因基因(06667)发布公告,该公司于2026年11月2日斥资39.76万港元回购5.66万股股份,每股回购价格为6.8-7.03港元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1517440.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06667","BK1219"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":0.0322},{"period":"1month","weight":-0.0316},{"period":"3month","weight":-0.0282},{"period":"6month","weight":-0.0051},{"period":"1year","weight":-0.0189},{"period":"ytd","weight":-0.0189}],"compareEarnings":[{"period":"1week","weight":-0.0519},{"period":"1month","weight":-0.0525},{"period":"3month","weight":-0.1384},{"period":"6month","weight":-0.1248},{"period":"1year","weight":-0.1326},{"period":"ytd","weight":-0.1256}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"美因基因有限公司是一家主要提供基因检测服务及癌症筛查服务的投资控股公司。该公司主要通过消费级基因检测分部和癌症筛查服务分部开展业务。该公司的检测服务包括脑健康评估检测套餐、营养吸收能力评估检测套餐、帕金森病风险评估、全面癌症风险评估套餐、心脑血管疾病风险评估套餐等。该公司也提供体外诊断(IVD)管线产品,包括消费级基因检测产品和疾病筛查产品。该公司主要在国内市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0,"avgChangeRate":-0.166378},{"month":2,"riseRate":0.75,"avgChangeRate":0.055076},{"month":3,"riseRate":0,"avgChangeRate":-0.048593},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.010548},{"month":5,"riseRate":0.666667,"avgChangeRate":0.005636},{"month":6,"riseRate":0.666667,"avgChangeRate":-0.015012},{"month":7,"riseRate":0.5,"avgChangeRate":0.008854},{"month":8,"riseRate":0.25,"avgChangeRate":-0.060544},{"month":9,"riseRate":0,"avgChangeRate":-0.127252},{"month":10,"riseRate":0.25,"avgChangeRate":-0.056658},{"month":11,"riseRate":0.25,"avgChangeRate":0.07952},{"month":12,"riseRate":0.666667,"avgChangeRate":0.22092}],"exchange":"SEHK","name":"美因基因","nameEN":"MEGA GENOMICS"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.54.0","shortVersion":"4.54.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"美因基因(06667)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供美因基因(06667)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"美因基因,06667,美因基因股票,美因基因股票老虎,美因基因股票老虎国际,美因基因行情,美因基因股票行情,美因基因股价,美因基因股市,美因基因股票价格,美因基因股票交易,美因基因股票购买,美因基因股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"美因基因(06667)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供美因基因(06667)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}